Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA

Approved

STANDARD

QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA

Laboratorios Salvat S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 28, 2022
Approval ID: dec08a73a389a0ef
Company: Laboratorios Salvat S.A.
Type: Standard

Approval Details

Approval Id: dec08a73a389a0ef
Drug Cima Aemps Name: QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA
Register Number: 88467
Holder Company Name: Laboratorios Salvat S.A.
Marketing Company Name: Laboratorios Salvat S.A.
Authorization Date: 2022-12-28
Dosage Form: SOLUCIÓN CUTÁNEA
Dose: 20 mg/ml / 0,7 ml/ml
Route Of Administration: USO CUTÁNEO
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Laboratorios Salvat S.A.

Active Ingredients

CLORHEXIDINA DIGLUCONATO

106,3 mg

ISOPROPIL ALCOHOL

549,5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 28, 2022

Approval ID

dec08a73a389a0ef

Type

Standard

Back to CIMA-AEMPS Approvals